SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-017724
Filing Date
2024-02-28
Accepted
2024-02-28 06:30:47
Documents
17
Period of Report
2024-02-26
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0200762-8k_180life.htm   iXBRL 8-K 47443
2 CERTIFICATE OF AMENDMENT OF SECOND AMENDED AND RESTATED CERTIFICATE OF INCORPORA ea0200762ex3-1_180life.htm EX-3.1 10688
3 GRAPHIC ex3-1_001.jpg GRAPHIC 18324
  Complete submission text file 0001213900-24-017724.txt   311848

Data Files

Seq Description Document Type Size
4 XBRL DEFINITION FILE atnf-20240226_def.xml EX-101.DEF 26629
5 XBRL LABEL FILE atnf-20240226_lab.xml EX-101.LAB 36680
6 XBRL PRESENTATION FILE atnf-20240226_pre.xml EX-101.PRE 25253
7 XBRL SCHEMA FILE atnf-20240226.xsd EX-101.SCH 3787
18 EXTRACTED XBRL INSTANCE DOCUMENT ea0200762-8k_180life_htm.xml XML 5839
Mailing Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306
Business Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306 650-507-0669
180 Life Sciences Corp. (Filer) CIK: 0001690080 (see all company filings)

IRS No.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38105 | Film No.: 24690066
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)